I'm starting to like this stock at the current price...
Company Press Release
SOURCE: Bradley Pharmaceuticals, Inc.
CARMOL(R) 40 U.S. Patent Allowed;
Studies Under Way;
Preliminary Findings Determine CARMOL(R) 40's Superior Efficacy vs. The
Leading Prescription Tissue-Softener
FAIRFIELD, N.J., April 20 /PRNewswire/ -- Bradley Pharmaceuticals, Inc. (Nasdaq: BPRX -
news) today announced it has received a notice of allowance from the U.S. Patent and Trademark
Office for a patent for its CARMOL® 40 product line, covering its proprietary urea formulation and
use.
The patent describes therapeutic applications for CARMOL® 40 for use as an important part of
comprehensive dermatological care.
Bradley Pharmaceuticals, Inc. Chairman & CEO, Daniel Glassman, stated, ''This patent offers
additional protection as we continue to learn more about the product's benefits. Moreover, ongoing
studies conducted by Dr. John Ademola of Biometrix Inc., San Francisco, CA, an independent
testing laboratory, compare CARMOL® 40 with the leading brand in the category, a product which
generates an estimated $50 million in annual revenue. Interim results, based upon two weeks of
therapy, are promising in terms of comparative product performance. We expect this study to be
completed and published, based upon four weeks of data, within the next few months. CARMOL®
40, as well as many of our other products, are available at leading pharmacies nationwide, including
through the internet at drugstore.com.''
Prescription-only CARMOL® 40 (40% urea cream) is a potent tissue softener used in the treatment
of thick, severely dry skin and also diseased or damaged nail tissue. The CARMOL® Family of
urea-based moisturizers include:
CARMOL® 10 (10% Urea) Total Body Lotion ... for dry skin
CARMOL® 20 (20% Urea) Extra Strength Enhanced Cream ... for deep
moisturizing.
CARMOL® HC (Hydrocortisone Acetate Cream USP, 1%), Rx Only ... for
dryness plus itching.
CARMOL® 40 (40% Urea) Rx Only ... for severely damaged skin and nails.
Bradley Pharmaceuticals, Inc. markets brandname products and over-the-counter pharmaceuticals
and health-related products throughout the United States as well as in 27 international markets.
Bradley Common A Shares (BPRX) are traded on the Nasdaq National Market System. |
